Craneware plc (LON:CRW) had its price objective raised by Peel Hunt from GBX 1,495 ($19.73) to GBX 1,800 ($23.75) in a research note issued to investors on Tuesday morning, Marketbeat reports. They currently have a buy rating on the stock.
Separately, N+1 Singer reissued a hold rating on shares of Craneware plc in a research note on Tuesday, September 5th.
Shares of Craneware plc (LON CRW) traded down GBX 15 ($0.20) during trading on Tuesday, hitting GBX 1,535 ($20.26). 6,823 shares of the stock were exchanged.
ILLEGAL ACTIVITY NOTICE: This piece was reported by BBNS and is the sole property of of BBNS. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/craneware-plc-crw-given-new-gbx-1800-price-target-at-peel-hunt/1746821.html.
The firm also recently disclosed a dividend, which will be paid on Thursday, December 7th. Shareholders of record on Thursday, November 9th will be paid a GBX 11.30 ($0.15) dividend. The ex-dividend date of this dividend is Thursday, November 9th. This represents a yield of 0.85%. This is a positive change from Craneware plc’s previous dividend of $8.70.
Craneware plc Company Profile
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.
Receive News & Ratings for Craneware plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware plc and related companies with our FREE daily email newsletter.